[New Date] BOPA’s Celebrate Pride Month Webinar

Due to an unforeseeable technical issue, we have had to reschedule our Celebrate Pride Month Webinar.

The new date is Thursday 13th June 2024 at 1pm BST.

If you have registered for the webinar on the original date, you don’t have to register again. A new Zoom link will be re-sent to you.

We hope to see you again on Thursday 13th.

 

Best Wishes,

BOPA EDI Subcommittee

====================================================================

 

To celebrate Pride Month, BOPA is organising a webinar on clinical considerations for the safe and effective prescribing for trans individuals living with cancer. This event will be amplified by the European Cancer Organisation who members will be able to join this event.

Date: Thursday, 13th June 2024 ; 13:00-14:00 UK time (14:00-15:00 CET)

 

Speakers:

Stewart O’Callaghan, Founder and CEO, OUTPATIENTs

Mariachiara D’Elia, Member of BOPA EDI sub-committee; pharmacist at Royal Marsden NHS Foundation Trust

Shereen Nabhani-Gebara, BOPA vice-chair and chair of EDI sub-committee; Associate professor of Oncology at Kingston University

 

In this session, the speakers will discuss the newly launched guide that supports healthcare professionals to deliver an inclusive consultation while considering pharmacokinetic, pharmacodynamic parameters that might influence prescribing decisions.

This guide is the result of a collaboration between OUTPATIENTs and BOPA.

 

Click here for more info.

 

This webinar is FREE for all BOPA members and associates.
BOPA members and associate click HERE to register
Click here to join BOPA

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article